Michael Saporito, Ph.D. is the Vice President of Research and Preclinical Development at Marinus Pharmaceuticals.

He brings nearly 30 years of pharmaceutical industry research experience to Marinus and is an accomplished biopharmaceutical leader with demonstrated success in identifying drug candidates and enabling their translation from early lead stage, through to development and proof of concept clinical studies. Dr. Saporito started his career at Cephalon Inc. where he led efforts in discovery of therapeutics for neurodegenerative diseases.  He also headed the biology research group at Locus Pharmaceuticals, cofounded Melior Discovery where he was Chief Scientific Officer and has consulted for emerging biopharmaceutical start-up companies and venture capital groups.

He is a member of Michael J. Fox Foundation review panel and has consulted for and advised multiple biopharmaceutical companies, venture capital groups and investment banks. Dr. Saporito has over 40 scientific publications, review articles, book chapters, and is an inventor on over 15 patents. Dr. Saporito is a graduate of Juniata College, obtained his Ph.D in Pharmacology at University of the Sciences in Philadelphia and completed his training as a postdoctoral fellow at Robert Wood Johnson Medical School in the Department of Neurology.